Wall Street Zen cut shares of Amdocs (NASDAQ:DOX – Free Report) from a buy rating to a hold rating in a research note published on Saturday.
A number of other research analysts have also issued reports on the company. Weiss Ratings reissued a “hold (c-)” rating on shares of Amdocs in a report on Friday, May 8th. Barclays decreased their price target on Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a report on Wednesday, February 4th. Cfra lowered shares of Amdocs to a “sell” rating in a research report on Thursday. Finally, Stifel Nicolaus dropped their price objective on shares of Amdocs from $88.00 to $71.00 and set a “buy” rating on the stock in a research note on Thursday. Three investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $86.67.
Read Our Latest Stock Analysis on DOX
Amdocs Price Performance
Amdocs (NASDAQ:DOX – Get Free Report) last issued its quarterly earnings results on Wednesday, May 13th. The technology company reported $1.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.77 by $0.01. The firm had revenue of $1.17 billion for the quarter, compared to analysts’ expectations of $1.17 billion. Amdocs had a return on equity of 19.67% and a net margin of 11.81%.The firm’s revenue for the quarter was up 3.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.78 EPS. Amdocs has set its FY 2026 guidance at 7.340-7.480 EPS and its Q3 2026 guidance at 1.810-1.870 EPS. On average, equities research analysts anticipate that Amdocs will post 7.41 earnings per share for the current year.
Amdocs Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be given a $0.569 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.28 annualized dividend and a yield of 3.8%. Amdocs’s dividend payout ratio is presently 45.60%.
Institutional Investors Weigh In On Amdocs
Several institutional investors have recently made changes to their positions in DOX. Quantinno Capital Management LP grew its stake in shares of Amdocs by 58.5% during the 1st quarter. Quantinno Capital Management LP now owns 215,907 shares of the technology company’s stock worth $14,090,000 after purchasing an additional 79,664 shares during the period. Lazard Asset Management LLC grew its stake in shares of Amdocs by 5.6% during the 1st quarter. Lazard Asset Management LLC now owns 34,350 shares of the technology company’s stock worth $2,242,000 after purchasing an additional 1,808 shares during the period. Rice Hall James & Associates LLC grew its stake in shares of Amdocs by 3.5% during the 1st quarter. Rice Hall James & Associates LLC now owns 238,140 shares of the technology company’s stock worth $15,541,000 after purchasing an additional 8,118 shares during the period. Entropy Technologies LP grew its stake in shares of Amdocs by 59.0% during the 1st quarter. Entropy Technologies LP now owns 41,757 shares of the technology company’s stock worth $2,725,000 after purchasing an additional 15,496 shares during the period. Finally, Renaissance Technologies LLC grew its stake in shares of Amdocs by 429.6% during the 1st quarter. Renaissance Technologies LLC now owns 291,800 shares of the technology company’s stock worth $19,043,000 after purchasing an additional 236,700 shares during the period. 92.02% of the stock is currently owned by hedge funds and other institutional investors.
Amdocs News Summary
Here are the key news stories impacting Amdocs this week:
- Positive Sentiment: Amdocs beat quarterly earnings estimates with EPS of $1.78 and matched revenue expectations at $1.17 billion, while revenue still rose 3.9% year over year. Amdocs earnings release and conference call
- Positive Sentiment: Management lifted fiscal 2026 guidance, signaling confidence in continued growth and profitability after the quarter. Zacks on Amdocs Q2 earnings
- Positive Sentiment: The company highlighted progress in GenAI and “agentic telco” initiatives, including launching Telco Agents in Google’s Gemini Enterprise marketplace. Amdocs Telco Agents announcement
- Positive Sentiment: Several new customer wins and platform expansions were announced, including deals with Lumen, Vodafone Ireland, Telefónica Móviles Argentina, and Qué tal Móvil, supporting backlog and long-term demand. Lumen and Amdocs cloud migration announcement
- Neutral Sentiment: Amdocs also announced its third-quarter investor conference schedule, which is routine investor-relations news rather than a direct business catalyst. Amdocs investor conference schedule
- Neutral Sentiment: The board declared a quarterly dividend, which is supportive for income investors but not likely the main driver of trading today.
Amdocs Company Profile
Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.
Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.
Featured Articles
- Five stocks we like better than Amdocs
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
